Canine Lymphoma: Diagnosis, Treatment, and Quality of Life

Lymphoma is one of the most common cancers in dogs, and advances in treatment have improved survival times while raising important questions about quality of life during therapy.

Key Facts

Lymphoma accounts for approximately 7-24% of all canine cancers
The CHOP chemotherapy protocol achieves remission in around 80-90% of cases
Median survival with treatment is approximately 12 months for multicentric lymphoma
Without treatment, most dogs survive only 4-6 weeks after diagnosis
Dogs generally tolerate chemotherapy better than humans with fewer severe side effects
Regular monitoring including bloodwork is essential throughout treatment

Welfare Considerations

Dogs with lymphoma face a complex welfare journey. While chemotherapy can extend life significantly, owners must weigh treatment intensity against quality of life. Nausea, fatigue, and infection risk are possible side effects. Palliative care focusing on comfort is a valid alternative for dogs where aggressive treatment is not appropriate. Open communication with oncology specialists and regular quality-of-life assessments help owners make informed, compassionate decisions.

What You Can Do

Consult a veterinary oncologist for a full assessment if lymphoma is suspected
Ask about quality-of-life metrics and palliative options alongside curative protocols
Keep detailed notes on appetite, energy, and behavior to track wellbeing
Connect with support communities for pet owners navigating canine cancer